BackProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares Overview

ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares Current Cash

ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares's current cash is $190M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$188.89M
↑ 2531.85% YoYΔ $181.71M vs prior year quarter

Peer average

Loading

ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares Current Cash History

Loading

ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares vs. peers: Current Cash Comparison

Loading

ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares (BIB) FAQ

As of the most recent data (December 2025), BIB shows a current cash of $190M. That compares with $7.2M in the prior-year period — up 2531.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIB's current cash is now $190M (was $7.2M) — a 2531.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares is outperforming or lagging.

Tracking BIB's current cash over time shows whether ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares is scaling, shrinking, or reshaping that part of the business. The current reading is $190M That compares with $7.2M in the prior-year period — up 2531.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $190M) with ownership activity and broader fundamentals.